Frontlight ResearchEarly access
Trial site
Kumagaya General Hospital
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis7 trials
- Phase
- Phase 36 trials
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- Abivax S.A.2 trials
- Janssen Research & Development, LLC2 trials
Running trials
Active, not recruiting
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Closed trials
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026